The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.

Researchers found that specific DNA segments in the malaria parasite trigger gene silencing, uncovering inherent control ...